Fundraising Fox

Enumeral Biomedical Holdings

Cambridge, US · Founded 2012 · Delaware corporation

Biotech

Founders & leadership

Enumeral Biomedical Holdings was founded in 2012 by Arthur H. Tinkelenberg, Ph.D..

AH
Arthur H. Tinkelenberg, Ph.D.Founder
KG
Kevin G. SarneyExecutive
AN
Anhco Nguyen, Ph.D.Executive
JJ
John J. RydzewskiExecutive
AH
Arthur H. TinkelenbergChief Executive Officer, President and Director
DB
Derek BrandVice President of Business Development and Secretary
AN
Anhco NguyenVice President of Research and Development

Board

DB
Daniel B. WolfeBoard director
AP
Allan P. RothsteinBoard director
BB
Barry Buckland, Ph.D.Board director
RJ
Robert J. EastonBoard director
PJ
Paul J. SekhriBoard director

Reported raises · per SEC filings

Form D private placements

$53.8M disclosed across 5 rounds · 2014–2017

▶$668KraisedMay 2017 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert L. Van NostrandDirector
  • Wael FayadExecutive Officer, Director
  • Barry Buckland, Ph.D.Director
  • Paul J. SekhriDirector
  • Robert J. EastonDirector
  • Allan P. RothsteinDirector
  • Kevin G. SarneyExecutive Officer
Offering amount
$3.6M
Amount sold
$668K
Sales commissions
$66.8K
Placement agents
GP NURMENKARI INC., Katalyst Securities LLC
First sale
May 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.4MraisedDec 2016 · 108 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Allan P. RothsteinDirector
  • Wael FayadExecutive Officer, Director
  • Barry Buckland, Ph.D.Director
  • Kevin G. SarneyExecutive Officer
  • Robert J. EastonDirector
  • Paul J. SekhriDirector
  • Robert L. Van NostrandDirector
Offering amount
$10.8M
Amount sold
$3.4M
Sales commissions
$255K
Placement agents
Katalyst Securities LLC
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedAug 2016 · 84 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Allan P. RothsteinDirector
  • Arthur H. Tinkelenberg, Ph.D.Director
  • Barry Buckland, Ph.D.Director
  • Robert J. EastonDirector
  • Kevin G. SarneyExecutive Officer
  • Anhco Nguyen, Ph.D.Executive Officer
  • John J. RydzewskiExecutive Officer, Director
  • Paul J. SekhriDirector
  • Robert L. Van NostrandDirector
Offering amount
$3.5M
Amount sold
$3M
Sales commissions
$30.4M
Placement agents
Katalyst Securities LLC
First sale
Jul 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.5MraisedAug 2014 · 253 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry BucklandDirector
  • Arthur H. TinkelenbergExecutive Officer, Director
  • Daniel B. WolfeDirector
  • Allan RothsteinDirector
  • Derek BrandExecutive Officer
  • John J. RydzewskiExecutive Officer, Director
  • Anhco NguyenExecutive Officer
  • Kevin SarneyExecutive Officer
Offering amount
$21.5M
Amount sold
$21.5M
Minimum investment
$100K
Sales commissions
$2.2M
Proceeds to insiders
$2.6M
Placement agents
EDI Financial, Inc., Katalyst Securities LLC
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.1MraisedAug 2014 · 79 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Arthur H. TinkelenbergExecutive Officer, Director
  • Daniel B. WolfeDirector
  • Anhco NguyenExecutive Officer
  • John J. RydzewskiExecutive Officer, Director
  • Kevin SarneyExecutive Officer
  • Barry BucklandDirector
  • Derek BrandExecutive Officer
  • Allan RothsteinDirector
Offering amount
$25.1M
Amount sold
$25.1M
First sale
Jul 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Enumeral Biomedical Holdings?
Enumeral Biomedical Holdings was founded by Arthur H. Tinkelenberg, Ph.D. in 2012.
How much funding has Enumeral Biomedical Holdings raised?
Enumeral Biomedical Holdings has disclosed $53.8M raised across 5 rounds.
Where is Enumeral Biomedical Holdings headquartered?
Enumeral Biomedical Holdings is headquartered in Cambridge, US.